Iino Conference Center Room B
Tokyo, Japan
Building on our successful 2021 workshop, the United States Pharmacopeia (USP) and Japan's Ministry of Health, Labour, and Welfare (MHLW)/Pharmaceutical and Medical Devices Agency (PMDA) invite you to a pivotal event shaping the future of pharmaceutical quality.
Workshop Highlights:
- Harmonization Progress: Discover advancements in active pharmaceutical ingredient, formulation, and excipient standards
- Emerging Collaborations: Explore new frontiers in qNMR and complex generics
- Critical Quality Issues: Gain insights on diethylene glycol/ethylene glycol and Nitrosamine challenges
- Global Perspectives: Learn about quality initiatives in Japan, East Asia, and beyond
- Future Outlook: Engage in discussions on the evolving roles of industry, agencies, and pharmacopeias